Nike vs. Lululemon: One Brand Is Losing Its Cool — and Investors Are Paying for It

Nike (NYSE:NKE | NKE Price Prediction) and Lululemon (NASDAQ:LULU) both reported earnings with North America struggling, China providing brightness, and tariffs compressing margins. Two athletic apparel giants face very different problems, with very different risks for investors.

Wholesale Saves Nike. China Saves Lululemon.

Nike’s quarter showed contradictions in the mix. Revenue came in at $11.28 billion, essentially flat year over year at 0.1%, but Wholesale revenues rose 5% to $6.5 billion while NIKE Direct fell 4% to $4.5 billion, and digital revenues within Direct dropped 9%.

CEO Elliott Hill’s pullback from the direct channel is working as intended. The brand is leaning on wholesale partners to rebuild marketplace health, and that bet is working in North America, where revenues climbed 3% to $5.03 billion.

But Converse collapsed 35% to $264 million, with no recovery signal in sight, and Greater China fell 7% to $1.62 billion. Gross margin compressed to 40.2%, down 130 basis points year over year, pressured by North America tariffs. EPS of $0.35 beat the $0.28 estimate, exceeding expectations, though net income fell 34.5% to $520 million due to a normalized tax rate.

Lululemon’s quarter looked cleaner on the surface. Revenue reached $3.64 billion, beating estimates by 1.81%, and China Mainland comparable sales surged 30%, while international revenue grew 17%. But Americas revenue declined 4%, and profitability was sobering.

Gross margin contracted 550 basis points to 54.9%, and EPS fell to $5.01 from $6.14 a year ago. Inventory grew 18% year over year, raising markdown risk heading into 2026.

One Brand Is Rebuilding. The Other Is Searching for Direction.

Nike’s strategy under Elliott Hill has a clear spine: restore wholesale relationships, reduce promotional noise, reinvest in sport-driven storytelling, and let the brand breathe. The “Win Now” initiative is now in its fourth consecutive quarter of beating EPS estimates.

Hill said plainly: “The work is not finished, but the direction is clear, our teams are moving with focus and urgency, and our foundation is getting even stronger to build the future of NIKE.”

That is a leader who knows what he is fixing. Restructuring costs are real, and tariff exposure in North America is a genuine headwind, but the playbook is visible.

Lululemon’s situation is more unsettling. The company operates under interim co-CEOs after Calvin McDonald’s departure, and FY2026 guidance tells a difficult story. Full-year EPS guidance of $12.10 to $12.30 implies a decline from the $13.26 earned in FY2025, and Q1 2026 EPS guidance of $1.63 to $1.68, which does not signal momentum.

The China story is real, and André Maestrini noted the company is “taking action to incorporate learnings from across our regions to drive forward our strategies,”, but applying international playbooks to a skeptical North American consumer is not straightforward. Inventory build and full-price sales pressure suggest discounting has not fully cleared.

The Next Test Is Full-Price Discipline and Tariff Clarity

For Nike, the watch item is whether wholesale recovery holds as tariff costs bite. The stock has fallen 17.09% in the month since earnings, and is down 27.79% year to date, suggesting the market has not yet rewarded the turnaround narrative. Footwear, the brand’s largest category at $7.35 billion, must regain real momentum in the next quarter.

For Lululemon, the question is whether North America discounting stabilizes before inventory forces deeper markdowns. China growth is impressive, but a premium global brand cannot be built on one geography while the home market erodes. The permanent CEO search outcome matters enormously. Without clarity, the drift continues.

Valuation and Risk Comparison

Neither stock is a simple buy. Nike trades at a forward P/E of roughly 23x, with a 3.67% dividend yield, and analyst consensus target of $63.64, against a current price of $45.70. The turnaround has a named leader, defined strategy, and four consecutive EPS beats.

Lululemon trades at a trailing P/E of 12x, with a consensus target of $183.80, versus a current price of $162.92, and 29 of 33 analysts rate it a Hold or worse. That skepticism is warranted.

Nike’s clearer management story and visible playbook reflect a more defined recovery timeline extending into 2027. Lululemon’s valuation is cheaper, but leadership uncertainty and North America headwinds create real risk.